17-82921536-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_005993.5(TBCD):c.2137C>T(p.His713Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000483 in 1,614,046 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005993.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBCD | NM_005993.5 | c.2137C>T | p.His713Tyr | missense_variant | 25/39 | ENST00000355528.9 | NP_005984.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBCD | ENST00000355528.9 | c.2137C>T | p.His713Tyr | missense_variant | 25/39 | 1 | NM_005993.5 | ENSP00000347719 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000682 AC: 17AN: 249278Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135230
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461710Hom.: 1 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727138
GnomAD4 genome AF: 0.000256 AC: 39AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74486
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.2137C>T (p.H713Y) alteration is located in exon 25 (coding exon 25) of the TBCD gene. This alteration results from a C to T substitution at nucleotide position 2137, causing the histidine (H) at amino acid position 713 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at